During the last six years (2012–2018), 26 cases of pathogenic mutations in CaM have been reported, and all three CALM genes are now established major genes for both CPVT and LQTS (Table 1). This evidence concerns the gene CALM2 and catecholaminergic polymorphic ventricular tachycardia.